Jared Tangney is the founder of Biolinq. Biolinq has raised $300M in total funding. Latest round: Series A. Backed by Mark Cuban.
Jared Tangney is the Co-Founder, President, and CTO of Biolinq, a San Diego-based diabetes technology startup that develops pain-free, skin-level continuous glucose monitors (CGMs). He translated university IP from UC San Diego into a venture-backed medtech platform and has led the company through multiple funding rounds.
Full founder directory · Investor directory · Company funding database · Fundraising library